The biotech sector has seen significant trading activity recently, particularly in the SPDR S&P Biotech ETF ($XBI) and the iShares Nasdaq Biotechnology ETF ($IBB). Notably, the highest trading volumes for $XBI occurred on two distinct occasions: the day following the 2016 election and the day after Robert F. Kennedy Jr.'s recent announcement, which has been described as a 'shockwave' in the market. Average trading volume for $XBI typically ranges between 7 to 8 million shares. Analysts are observing a potential reversal pattern in both ETFs, with indications that $IBB is oversold in the near term. The recent trading days have shown a bounce in prices, suggesting a recovery in the biotech sector, despite a generally weak market environment.